• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Catalog Number 1120300-38
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Angina (1710); Headache (1880); Claudication (2550); No Code Available (3191)
Event Date 08/03/2016
Event Type  Injury  
Manufacturer Narrative
(b)(4).The stent remains in the patient.Investigation is not yet complete.A follow up report will be submitted with all relevant information.
 
Event Description
It was reported that the procedure was to treat an unspecified lesion in the left anterior descending artery.On (b)(6) 2016 a 3x38mm xience alpine stent was implanted.Approximately 15 days later the patient began feeling pain in the arm and chest.The pain increased over time and the patient could not walk due to pain in the legs.The patient experienced headaches and pain in the neck.The patient went to a local clinic for his symptoms but the clinic referred the patient to a hospital.No additional information was provided.
 
Manufacturer Narrative
(b)(4).The device was not returned for evaluation.A review of the lot history record and complaint history of the reported lot could not be conducted because the lot number was not provided.Based on the case information and related record review, a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.Additionally, the treatment appears to be related to the operational context of the procedure.Angina, fatigue, headache, and pain are listed in the xience alpine everolimus eluting coronary stent systems instructions for use as known patient effects of coronary stenting procedures.Based on the information reviewed, there is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Event Description
Subsequent to filing the initial mdr, additional information was received which indicates that the patient was experiencing chest and arm pain before and after stent implantation.On (b)(6) 2016, 15 days after the stent was implanted the patient became symptomatic with the following: pain the in the legs, arms and chest, headaches, tickling and numbness in his head, eyes and neck and fatigue after walking.The patient was admitted to hospital (b)(6) emergency room (er) on (b)(6) 2016 where the attending physician provided the patient with injections of voltaren.On (b)(6) 2016 an electrocardiogram (ekg) was performed by a general practitioner and results were slightly abnormal.A myocardial infarction was not diagnosed.No angiogram was performed; thus, the status of the stent was unknown.It was confirmed, however, that the patient continues taking plavix.Although the patient does not have test results an appointment was scheduled for (b)(6) 2017 at (b)(6) hospital with a cardiologist.No further information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, TEMECULA, CA USA REG# 2024168
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
connie speck
abbott vascular
26531 ynez road
temecula, CA 92591-4628
9519143996
MDR Report Key6038617
MDR Text Key57774436
Report Number2024168-2016-07057
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeCS
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Reporter Occupation Patient
Remedial Action Other
Type of Report Initial,Followup
Report Date 11/04/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number1120300-38
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 09/28/2016
Initial Date FDA Received10/18/2016
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received11/04/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other;
Patient Age57 YR
-
-